Carcinoid and neuroendocrine tumor (NET) patients, physicians, caregivers, support group leaders and patient advocates gathered to learn more from nationally and internationally recognized carcinoid/NET specialists and local physician specialists on November 2, 2013 for the New Jersey Carcinoid Cancer NETwork Conference.
The opening video shares the patient, physician, support group leader, and patient advocate perspective about the value of attending carcinoid/NET conferences. It’s a terrific introduction to the New Jersey Conference!!
The guest speakers were:
- Dr. Richard R.P. Warner, Carcinoid/NETs – A Brief Review and Comments on Recent Developments
- Dr. Justina Deitz, Neuroendocrine Symptoms and Diseases Associated with Carcinoid
- Dr. Eric H. Liu, Everything You Always Wanted to Know About PRRT, But Didn’t Know Who to Ask
- Dr. Yi-Zarn Wang, Surgical Treatment of Neuroendocrine Tumors: What’s New, What’s Next
- Question and Answers
In addition to the physicians’ presentations on video, their PowerPoint presentations are available for downloading.
- Dr. Warner’s Presentation, click here
- Dr. Deitz’s Presentation, click here
- Dr. Liu’s Presentation, click here
- Dr. Wang’s Presentation, click here
A wonderful unanticipated part of the program took place when Elyse Spatz Caplan, Novartis Oncology’s Director of Patient Advocacy, Public Affairs and Communications, presented the 2013 Warner Advocacy Award to Jim Weiveris.
With special thanks to Flying Flounder Productions for creating the conference videos.
For more videos from previous conferences, please visit the Carcinoid Cancer Foundation’s website, https://www.carcinoid.org/content/videos and for additional videos with carcinoid/neuroendocrine tumor specialists and patients, visit CCF’s YouTube channel, http://www.youtube.com/user/CarcinoidNETs. There are videos on everything from the ABC’s of Carcinoid and Neuroendocrine Tumors to Surgery and Treatment Options, Lung Carcinoid, Living Well with Carcinoid and Neuroendocrine Tumors and Nutrition and Neuroendocrine Tumors.